:: CLDF ::

Home | Contact Us | Bookmark

MASH

HCC

ALCOHOL LIVER DISEASE

PEDIATRIC LIVER DISEASE

Embassy of Education

Webcasts & Podcasts Abstract Library Committee Members

HCV | Abstract Library

The summaries are free for public use. The Chronic Liver Disease Foundation will continue to add and archive summaries of articles deemed relevant to CLDF by the Board of Trustees and its Advisors.

1.	Age-period-cohort and bayesian age-period-cohort prediction modeling of hepatitis C incidence and mortality in China.
	BMC Public Health.2025 Jun 04;25(1):2079.doi:10.1186/s12889-025-22847-5
	Lin, Fei (F);Liu, Zhenzhou (Z);Zhai, Jianli (J);Yi, Shibei (S);Li, Yanyan (Y);Wang, Yongbin (Y);

2.	Local data for local programming: Results from an HIV biobehavioral survey among people who inject drugs in Livingstone, Lusaka, and Ndola, Zambia, 2021.
	PLoS One.2025 May 27;20(5):e0323919.doi:10.1371/journal.pone.0323919
	Woytowich, Daniel (D);McIntyre, Anne F (AF);Solomon, Hiwote (H);Hanunka, Brave (B);Chelu, Lazarus (L);Nkumbula, Tepa (T);Tally, Leigh (L);Handema, Ray (R);Khondowe, Shepherd (S);Kapungu, Kelvin (K);Chilukutu, Lophina (L);Bwalya, Innocent (I);Mulemfwe, Chipili (C);Mwansa, Melvin (M);Mutale, Kennedy (K);Philip, Neena M (NM);Reid, Giles (G);Neal, Joyce J (JJ);Lahuerta, Maria (M);Parmley, Lauren E (LE);Chung, Hannah (H);Hakim, Avi J (AJ);Hines, Jonas Z (JZ);Kim, Evelyn (E);Mwale, John (J);Mulenga, Lloyd B (LB);

3.	Discreet but accessible: a qualitative study with people who use drugs and service staff about the optimal design of a harm reduction vending machine in rural Kentucky.
	Harm Reduct J.2025 May 28;22(1):88.doi:10.1186/s12954-025-01222-y
	Marschke, Rachel M (RM);Young, April M (AM);Knudsen, Hannah K (HK);Cheatom, Chelsi N (CN);Cooper, Hannah L F (HLF);

4.	Simplified and Integrated Hepatitis C Virus Testing and Treatment Algorithm for Unhoused People Who Inject Drugs.
	Open Forum Infect Dis.2025 May 22;12(6):ofaf302.doi:10.1093/ofid/ofaf302
	Ramers, Christian B (CB);Vawter, Natalie (N);Northrup, Adam (A);Klaman, Stacey L (SL);Lewis, Sydney V (SV);Tam, Aaron (A);Del Aguila, Carolina (C);Lewis, Robert (R);Mendez, Blanca (B);Reyes, Letty (L);Matthews, Eva (E);Rojas, Sarah (S);Godino, Job G (JG);

5.	Immunohistochemical expression of PD1, LAG3, and CTLA4 in diffuse large B cell lymphoma, clinicopathological correlation, and prognostic value.
	J Egypt Natl Canc Inst.2025 Jun 07;37(1):47.doi:10.1186/s43046-025-00303-0
	William, Madonna I (MI);Tantawy, Dina A (DA);Elsergany, Alyaa R (AR);El-Hawary, Amira K (AK);Yussif, Shaimaa M (SM);

6.	Oral manifestations in patients with chronic hepatitis C.
	BMC Oral Health.2025 Jun 09;25(1):944.doi:10.1186/s12903-025-06307-5
	Brzd?k, Micha? (M);Ga?uszka-Garnuszek, Joanna (J);Dobrowolska, Krystyna (K);Brzd?k, Kinga (K);Janczura, Jakub (J);Tronina, Olga (O);Kal, Magdalena (M);St?pie?, Piotr (P);Zar?bska-Michaluk, Dorota (D);

7.	Utilizing Theory of Planned Behaviour to increase intention to participate in hepatitis C treatment therapy among Methadone maintenance therapy clients (MMT) in Malaysia: A cluster randomised control trial.
	PLoS One.2025 May 22;20(5):e0324718.doi:10.1371/journal.pone.0324718
	Baharudin, Mohd Hafiidz (MH);Mokhtar, Siti Aisah (SA);Azman, Ahmad Zaid Fattah (AZF);Mohd Nazan, Ahmad Iqmer Nashriq (AIN);

8.	Impact of hepatitis C virus genotype on the efficacy of the direct-acting antivirals in chronic kidney disease patients in West Bengal, India.
	BMC Infect Dis.2025 May 16;25(1):706.doi:10.1186/s12879-025-10947-x
	Bakshi, Sagnik (S);Dutta, Supradip (S);Biswas, Aritra (A);Das, Raina (R);Nath, Shreyasi (S);Ghosh, Anwesha (A);Baskey, Upasana (U);Sadhukhan, Provash Chandra (PC);

9.	Hepatitis C Testing in the US Veterans Health Administration: Uptake of United States Preventive Services Taskforce Universal Hepatitis C Screening Guidance.
	Open Forum Infect Dis.2025 May 16;12(5):ofaf249.doi:10.1093/ofid/ofaf249
	Varley, Cara D (CD);Beste, Lauren A (LA);Lowy, Elliott (E);Morgan, Timothy R (TR);Ross, David B (DB);Maier, Marissa M (MM);

10.	The macroeconomic burden of hepatitis C and the economic benefit of accelerated investments in China.
	BMC Public Health.2025 May 13;25(1):1743.doi:10.1186/s12889-025-22853-7
	Bao, Yun (Y);Chen, Ying (Y);Jin, Huajie (H);Zhang, Chi (C);Zhang, Lingli (L);Wu, Bin (B);

11.	Prescribing direct-acting antivirals for hepatitis C treatment: a scoping review of factors that influence primary care providers.
	BMC Prim Care.2025 May 13;26(1):157.doi:10.1186/s12875-025-02865-3
	Hallett, Jonathan (J);Price, Tina (T);Gray, Corie (C);Rosenberg, Shoshana (S);Lobo, Roanna (R);Crawford, Gemma (G);

12.	Rapid onset of neurological symptoms in an HIV-positive patient with progressive multifocal leukoencephalopathy: a case report.
	Ann Med Surg (Lond).2025 May 12;87(6):3994-3998.doi:10.1097/MS9.0000000000003351
	Waqas, Sameeka (S);Iqbal, Umer (U);Khurram, Laiba (L);Saleem, Ahmed (A);Ain, Qurrat Ul (QU);Butt, Mujeeb-Ur-Rehman Abid (MA);Okon, Inibehe Ime (II);

13.	Incidence, Patient-Directed Discharge, Readmission, and Mortality Among People Hospitalized With Injecting-Related Infection: A Population-Based Linkage Study.
	Open Forum Infect Dis.2025 Apr 29;12(5):ofaf257.doi:10.1093/ofid/ofaf257
	Masters, Jeffrey (J);Jacka, Brendan (B);Barault, Marion (M);Goodman-Meza, David (D);Russell, Danielle (D);Matthews, Gail V (GV);Dore, Gregory J (GJ);Valerio, Heather (H);Martinello, Marianne (M);

14.	Abnormal Trabecular and Cortical Bone Microarchitecture in Chronic Hepatitis C Infection and Associations With Select Inflammatory Cytokines.
	Open Forum Infect Dis.2025 Apr 29;12(5):ofaf102.doi:10.1093/ofid/ofaf102
	Weinstein, Erica J (EJ);Carbonari, Dean M (DM);Newcomb, Craig W (CW);Torgersen, Jessie (J);Smith, Shanae M (SM);Brecker, Katherine L (KL);Liu, X Sherry (XS);Kostman, Jay R (JR);Trooskin, Stacey (S);Hubbard, Rebecca A (RA);Baker, Joshua F (JF);Zemel, Babette S (BS);Leonard, Mary B (MB);Lo Re, Vincent (V);

15.	SVR timelines in hepatitis - C irrespective of viral genotype: An Indian perspective.
	J Family Med Prim Care.2025 Apr 25;14(4):1425-1430.doi:10.4103/jfmpc.jfmpc_1780_24
	Sagar, Nambaru Vidya (NV);Goyal, Anamika (A);Raj, Abhishek (A);Chandra, Subhash (S);Gupta, Upendra Nath (UN);Agrawal, Prabhat (P);Gupta, Rajat (R);Agrahari, Rahul (R);

16.	Prevalence-based screening by anti-HCV reflex HCV antigen test and accessible post-screening care towards elimination of hepatitis C in rural villages.
	BMC Gastroenterol.2025 May 23;25(1):400.doi:10.1186/s12876-025-03990-0
	Pan, Kuan-Chen (KC);Hsu, Nien-Tzu (NT);Tang, Ying-Mei (YM);Lee, Yu-Chen (YC);Kuo, Hsiu-Ling (HL);Huang, Tung-Jung (TJ);Tseng, Chun-Mei (CM);Lu, Sheng-Nan (SN);Chang, Te-Sheng (TS);

17.	Acceptability and usability of oral fluid HCV self-testing among health-facility users from Brazil: a cross-sectional study of 685 participants.
	Braz J Infect Dis.2025 May 23;29(4):104544.doi:10.1016/j.bjid.2025.104544
	Perazzo, Hugo (H);Villela-Nogueira, Cristiane (C);Gomes, Maria K (MK);Daher, Andre (A);Siqueira-do-Valle, Cristiane (C);Zukeram, Ketiuce (K);Ferreira, Ana Cristina G (ACG);Tonini, Karen Cristine (KC);de Almeida, Elton Carlos (EC);Cardoso, Sandra W (SW);Grinsztejn, Beatriz (B);Veloso, Valdilea G (VG);

18.	Association between hepatitis C virus infection and rheumatoid arthritis: a nationwide cross-sectional study.
	BMC Rheumatol.2025 May 26;9(1):61.doi:10.1186/s41927-025-00513-y
	Tang, Lin (L);Zhang, Lei (L);Ding, Zhonghai (Z);Xu, Wenying (W);Liu, Yu (Y);Yu, Zhenghong (Z);

19.	Pilot Findings From the First Legalized Mobile Retail Pharmacy Clinic in the United States for Infectious Disease Treatment and Prevention Tailored to Reach People Who Use Drugs.
	Open Forum Infect Dis.2025 Apr 24;12(4):ofaf200.doi:10.1093/ofid/ofaf200
	Tarfa, Adati (A);Di Paola, Angela (A);Frank, Cynthia A (CA);Schultheis, Alysse M (AM);Brooks, Ralph (R);Shenoi, Sheela V (SV);Springer, Sandra A (SA);

20.	Comprehensive Care for People Who Use Drugs: Combining Infectious Diseases Services, Harm Reduction, and Primary Care.
	Open Forum Infect Dis.2025 Apr 16;12(5):ofaf226.doi:10.1093/ofid/ofaf226
	Knodle, Ryan D (RD);Messmer, Sarah E (SE);Murphy, Albert L (AL);Smith, Renata O (RO);Huyck, Michael (M);Cotler, Karen (K);Jimenez, Antonio D (AD);Mayer, Stockton M (SM);

21.	Getting to full disclosure: HCV testing and status disclosure behaviors among PWID and their injecting partners.
	BMC Public Health.2025 May 08;25(1):1707.doi:10.1186/s12889-025-22781-6
	Scarpetta, Maia (M);Kanner, Rachel (R);Menezes, Neia Prata (NP);McDonell, Claire C (CC);Bruneau, Julie (J);Page, Kimberly (K);Morris, Meghan D (MD);

22.	Approaches to Offering Hepatitis C Treatment at Syringe Services Programs in the United States: A Scoping Review.
	Open Forum Infect Dis.2025 Apr 08;12(4):ofaf211.doi:10.1093/ofid/ofaf211
	Yoder, Theodore (T);Hirose, Kyoko (K);Tsui, Judith I (JI);Feinberg, Judith (J);Hagan, Holly (H);Pho, Mai T (MT);Rowan, Sarah E (SE);

23.	Enhancing public health surveillance: SARIMAX model incorporating Baidu search index for HCV prediction in China.
	BMC Med Res Methodol.2025 Apr 23;25(1):108.doi:10.1186/s12874-025-02562-w
	Ning, Huan (H);Lan, Yingji (Y);Huang, Qianqian (Q);Luo, Tingyan (T);Yang, Jing (J);Zhou, Jie (J);Li, Zhuoxin (Z);Cui, Ping (P);Liang, Hao (H);Huang, Jiegang (J);

24.	Lytic bone lesion of the skull as a rare manifestation of hepatocellular carcinoma: a case report.
	Patient Saf Surg.2025 Apr 22;19(1):12.doi:10.1186/s13037-025-00434-2
	Wael, Sherif (S);Hamdy, Omar (O);Yasser, Mohamed (M);Elmandrawi, Sara (S);Mostafa, Mai (M);Mohammed, Nouran (N);Elghrieb, Ahmed (A);

25.	Evaluation of an anti-HCV chemiluminescence assay: Enhancing diagnostic accuracy and reducing false positives in hepatitis C screening.
	Diagn Microbiol Infect Dis.2025 Apr 03;112(3):116829.doi:10.1016/j.diagmicrobio.2025.116829
	Zheng, Qingyuan (Q);He, Yong (Y);Zhu, Quanjing (Q);Wang, Chi (C);Nie, Xin (X);

26.	Influencing factors of HCV testing willingness among men who have sex with men in China: A structural equation modeling analysis.
	PLoS One.2025 Apr 03;20(4):e0321469.doi:10.1371/journal.pone.0321469
	Li, Jiayan (J);He, Jing (J);Yang, Guohui (G);Cao, Zhen (Z);Zhong, Xiaoni (X);

27.	Temporal and geospatial patterns of hepatitis C virus prevalence: a longitudinal examination using national health insurance service data in the Republic of Korea (2005-2022).
	BMC Public Health.2025 Apr 03;25(1):1248.doi:10.1186/s12889-025-21777-6
	Choi, Hwa Young (HY);Ki, Moran (M);

28.	Prescription patterns of comedications associated with drug-drug interactions risk in HCV-infected patients undergoing direct-acting antiviral treatment: an analysis of an administrative claims database in Japan.
	J Pharm Health Care Sci.2025 Apr 18;11(1):33.doi:10.1186/s40780-025-00442-5
	Nakamoto, Daisuke (D);Piao, Yi (Y);Mizutani, Hajime (H);Wakabayashi, Ryozo (R);Otokita, Satoshi (S);Stead, Alice (A);Hernandez, Candido (C);Jinushi, Masahisa (M);

29.	Evaluating the Risk of Hepatitis B, Hepatitis C, and Human Immunodeficiency Virus Among High-risk Deferred Blood Donors, Based on Deferral Reasons.
	Arch Iran Med.2025 Mar 01;28(3):155-161.doi:10.34172/aim.33374
	Riyahi, Sara (S);Teimourpour, Amir (A);Amini-Kafiabad, Sedigheh (S);Maghsudlu, Mahtab (M);Sharifi, Zohreh (Z);Minai-Tehrani, Dariush (D);

30.	Determination of the Viremia and Genotype Distribution of the Hepatitis C Virus and the Seroprevalence of HIV Co-Infection.
	Infect Dis Clin Microbiol.2025 Mar 27;7(1):27-36.doi:10.36519/idcm.2025.447
	Ak?ll?, Fatih Mehmet (FM);Turan-Gökçe, Dilara (D);Ak?ll?, Beste (B);

31.	Providers' Perspectives on Implementation of Low-threshold HCV Treatment in New York State: A Qualitative Study.
	Open Forum Infect Dis.2025 Mar 26;12(4):ofaf184.doi:10.1093/ofid/ofaf184
	Finbråten, Ane-Kristine (AK);Chin, Cristina L (CL);Seetharaman, Meenakshi (M);Hutchings, Kayla (K);Eckhardt, Benjamin J (BJ);Schackman, Bruce R (BR);Kapadia, Shashi N (SN);

32.	Feasibility of a prison-based test-and-treat model for enhancing hepatitis C care in Kedah, Malaysia.
	BMC Public Health.2025 Mar 26;25(1):1152.doi:10.1186/s12889-025-22296-0
	Suan, Mohd Azri Mohd (MAM);Zulkifli, Ahmad Muaz (AM);Ani, Noor Hidayati (NH);Azlan, Azlina (A);Mustafa, Mohamad Faiz (MF);Ali, Siti Maisarah Md (SMM);Aris, Siti Aishah (SA);Nizar, Nur Aisyah Sakinah Muhamad (NASM);Fahami, Fatihah Fahami Mohd Najib (FFMN);Othman, Amizah (A);Chan, Huan-Keat (HK);Hassan, Muhammad Radzi Abu (MRA);

33.	Sustained Impact of Task-shifting HCV Treatment to Nonspecialist Providers: 5-Year Follow Up of the ASCEND Investigation.
	Open Forum Infect Dis.2025 Mar 22;12(4):ofaf174.doi:10.1093/ofid/ofaf174
	Mollenkopf, Sarah (S);Rosenthal, Elana (E);Teferi, Geb (G);Silk, Rachel (R);George, Nivya (N);Masur, Henry (H);Kottilil, Shyam (S);Kattakuzhy, Sarah (S);

34.	Prevalence and Factors Associated With Sexually Transmitted Infections Among People who Inject Drugs in the San Diego-Tijuana Border Region.
	Open Forum Infect Dis.2025 Mar 21;12(4):ofaf171.doi:10.1093/ofid/ofaf171
	Nacht, Carrie L (CL);Strathdee, Steffanie A (SA);Harvey-Vera, Alicia (A);Vera, Carlos F (CF);Rangel, Gudelia (G);Klausner, Jeffrey D (JD);Artamonova, Irina (I);Abramovitz, Daniela (D);Skaathun, Britt (B);

35.	Psychiatrist-led hepatitis C (HCV) treatment at an opioid agonist treatment clinic in Stockholm- a model to enhance the HCV continuum of care.
	BMC Psychiatry.2025 Mar 27;25(1):291.doi:10.1186/s12888-025-06733-3
	Klasa, Per-Erik (PE);Sandell, Mikael (M);Aleman, Soo (S);Kåberg, Martin (M);

36.	Initial Real-World Pilot of the MedMorph Reference Architecture: Hepatitis C Surveillance and Research.
	Appl Clin Inform.2025 Mar 12;16(2):234-244.doi:10.1055/a-2441-6100
	Michaels, Maria (M);Botts, Nathan E (NE);Hassell, Susan (S);Mardon, Russell (R);Pan, Eric Chung Ren (ECR);Flanigan, Mike (M);Chehab, Chirine (C);Liu, Sara (S);Bocour, Angelica (A);Alexander, Mark (M);Aponte, Angel (A);Thompson, Nicola D (ND);

37.	Integrative analysis of serum proteomics and transcriptomics in hepatitis C.
	Virol J.2025 Mar 13;22(1):73.doi:10.1186/s12985-025-02690-1
	Wang, Jianqiong (J);Xia, Andong (A);Tang, Min (M);Yang, Shengjun (S);Shen, Yandi (Y);Dao, Jinhua (J);Tao, Rui (R);Yue, Wei (W);

38.	Offering is not enough: an attempt to increase infectious diseases testing at a large county jail in Massachusetts.
	Health Justice.2025 Mar 15;13(1):15.doi:10.1186/s40352-024-00299-0
	Grussing, Emily D (ED);Sato, Taisuke (T);Cabrera, Alyssa (A);Wurcel, Alysse G (AG);

39.	Epidemiological characteristics and spatiotemporal distribution of hepatitis C in southeast coastal areas of China from 2015 to 2022.
	BMC Infect Dis.2025 Mar 21;25(1):394.doi:10.1186/s12879-025-10778-w
	Liu, Wei (W);Lian, Qiaoling (Q);Li, Zongqing (Z);Lu, Xiaoli (X);Wu, Shaobin (S);Zhang, Mingya (M);Pan, Yunjiao (Y);Lin, Yixiang (Y);Xie, Jianfeng (J);

40.	Psychosomatic and Psychological Impact of Hepatitis C: A Cross-Sectional Study of Depression, Fibrosis, and Somatic Symptoms in Treatment-Naive and Treatment-Experienced Patients Who Achieved Sustained Virologic Response.
	Cureus.2025 Mar 05;17(3):e80104.doi:10.7759/cureus.80104
	Rashid, Ahmad A (AA);Rashid, Akhtar (A);Zahra, Muqadas (M);Aslam, Noman (N);Jameel, Safa (S);Awais, Hafiz M (HM);Zaheer, Hamas (H);

41.	A diagnostic target in the 3' untranslated region of hepatitis C virus genome.
	Mol Biol Rep.2025 Apr 07;52(1):367.doi:10.1007/s11033-025-10480-9
	Ampoot, Weenassarin (W);Chujan, Suthipong (S);Kiattanaphon, Anusorn (A);Sistayanarain, Anchalee (A);

42.	Epidemiological trends of hepatitis C incidence and death in Mainland China between 2004 and 2018 and its predictions to 2030.
	BMC Infect Dis.2025 Apr 08;25(1):483.doi:10.1186/s12879-025-10881-y
	Tian, Guo (G);Zheng, Yang (Y);He, Yinghua (Y);Chen, Can (C);Zhang, Xiaobao (X);Du, Yuxia (Y);Yang, Shigui (S);Jiang, Tianan (T);Li, Lanjuan (L);

43.	Finding the Context of High-Risk Behavioral Factors and the Effectiveness of Addiction Treatment Centers in Preventing the Transmission of Hepatitis C Virus Among Injecting Drug Addicts: "Southeastern Iran".
	Health Sci Rep.2025 Mar 03;8(3):e70501.doi:10.1002/hsr2.70501
	Asadi, Neda (N);Pourkhajoei, Sirous (S);

44.

Update on Pediatric Hepatitis C Infection

Curr Gastroenterol Rep.?2025 Feb 28;27(1):18.?doi: 10.1007/s11894-024-00955-3.

Johanna Ferreira?1,?Shari Sheflin-Findling?2

45.

Impact of a minimal monitoring HCV treatment approach on Health-Related Quality of Life

Qual Life Res.?2025 Feb 28.?doi: 10.1007/s11136-025-03922-1.?Online ahead of print.

Thiago S Torres?1,?Pooja T Saha?2,?Laura Smeaton?2,?Chanelle Wimbish?3,?Dimas Alexandre Kliemann?4,?Anchalee Avihingsanon?5,?Cissy Kityo?6,?Jaclyn Ann Bennet?7,?Marije Van Schalkwyk?8,?Benjamin Linas?9,?Estevao Portela Nunes?10,?Gregory K Robbins?11,?David Wyles?12,?Susanna Naggie?13,?Mark Sulkowski?14,?Sandra Wagner Cardoso?10,?Sunil Solomon?14

46.

Liver fibrosis regression in people living with HIV after successful treatment for hepatitis C

J Acquir Immune Defic Syndr.?2025 Feb 20.?doi: 10.1097/QAI.0000000000003646.Online ahead of print.

Jim Young?1?2,?Shouao Wang?2,?Rachel Sacks-Davis?3,?Ashleigh Stewart?3,?Daniela K van Santen?3,?Marc van der Valk?4?5,?Joseph S Doyle?3?6,?Gail Matthews?7,?Juan Berenguer?8,?Linda Wittkop?9,?Karine Lacombe?10,?Andri Rauch?11,?Mark Stoové?3,?Margaret Hellard?3?6,?Marina B Klein?1?2?12;?InCHEHC Collaboration

47.

Prediction of Hepatitis C Virus Perinatal Transmission in Pregnant Individuals With Hepatitis C Virus Infection

Obstet Gynecol.?2025 Feb 27.?doi: 10.1097/AOG.0000000000005872.?Online ahead of print.

Grecio J Sandoval?1,?George R Saade,?Brenna L Hughes,?Rebecca G Clifton,?Uma M Reddy,?Anna Bartholomew,?Ashley Salazar,?Edward K Chien,?Alan T N Tita,?John M Thorp Jr,?Torri D Metz,?Ronald J Wapner,?Vishakha Sabharwal,?Hyagriv N Simhan,?Geeta K Swamy,?Kent D Heyborne,?Baha M Sibai,?William A Grobman,?Yasser Y El-Sayed,?Brian M Casey,?Samuel Parry,?George A Macones,?Mona Prasad;?Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network

48.

The Key Importance of Screening Underprivileged People in Order to Achieve Global Hepatitis Virus Elimination Targets

Viruses.?2025 Feb 14;17(2):265.?doi: 10.3390/v17020265.

Laura Gragnani?1,?Monica Monti?2,?Irene De Giorgi?1,?Anna Linda Zignego?2

49.	The interplay of socio-demographic factors and disease prevalence: insights into malaria, Hepatitis B, and Hepatitis C in Lafia, Nasarawa State, Nigeria.
	J Health Popul Nutr.2025 Mar 06;44(1):67.doi:10.1186/s41043-025-00779-5
	Aremu, Dorcas Oluwakemi (DO);Maxim, Antipov (A);Aremu, Stephen Olaide (SO);Aremu, Damilola Esther (DE);Terhemen, Yakubu Daniel (YD);Itodo, Samuel Olusegun (SO);Barkhadle, Abdillahi Abdi (AA);

50.	Changes in the presentation and characteristics OF HCV related hepatocellular carcinoma in the era of direct acting antiviral therapy: A retrospective study.
	Clin Res Hepatol Gastroenterol.2025 Mar 03;49(4):102567.doi:10.1016/j.clinre.2025.102567
	Abdelmoneim, Randa Salah (RS);Sedki, Fathalla (F);Bakosh, Mohamed Fathy (MF);

51.	The impact of restricted community accessibility on needle and syringe sharing among drug users in Baise city: based on the event study method.
	BMC Public Health.2025 Mar 08;25(1):928.doi:10.1186/s12889-025-22088-6
	Li, Xujiao (X);Tan, Lanfen (L);Chen, Jian (J);Zhang, Ruchen (R);Zeng, Weide (W);Liu, Chang (C);Xie, Mengyao (M);Liang, Wangjin (W);Liang, Xu (X);Qi, Guangzi (G);

52.	Directly acting antivirals improve insulin resistance in nondiabetic patients with hepatitis C: a systematic review and meta-analysis.
	Ann Med Surg (Lond).2025 Feb 28;87(4):2255-2262.doi:10.1097/MS9.0000000000003081
	Lamichhane, Pratik (P);Makhlouf, Saed S K (SSK);Saleem, Kanza (K);Senliya, Darshan (D);Wajid, Afreen (A);Khanal, Kapil (K);Agrawal, Anushka (A);

53.	A Study to Understand the Reasons for Early Treatment Discontinuation among People Living with Hepatitis C in Punjab, India.
	Indian J Public Health.2025 Mar 21;69(1):3-9.doi:10.4103/ijph.ijph_871_23
	Mutreja, Karishma (K);Boeke, Caroline E (CE);Tandon, Roli (R);Witschi, Magdalena (M);Sindhwani, Siddharth (S);Chawla, Umesh (U);Gaugna, Shalu (S);Grover, Gagandeep Singh (GS);

54.	Assessing user experience with the Bioline™ HCV point-of-care test in primary healthcare settings: a mixed-methods study.
	BMC Health Serv Res.2025 Apr 01;25(1):484.doi:10.1186/s12913-025-12634-8
	Duah, Evans (E);Mathebula, Evans Mantiri (EM);Maluleke, Kuhlula (K);Baloyi, Tinyiko Violet (TV);Ephraim, Richard Kobina Dadzie (RKD);Mashamba-Thompson, Tivani (T);

55.	Hepatitis C virus seroprevalence in defined populations in New Zealand: data from a general practice-based screening programme.
	N Z Med J.2025 Feb 28;138(1610):52-59.doi:10.26635/6965.6596
	Tiong, Ho Tuan (HT);Upton, Arlo (A);Lockie, Angelle (A);Moore, Kirsty (K);Stedman, Catherine A M (CAM);

56.

Hepatitis C associated mixed cryoglobulinemia glomerulonephritis in the setting of undetectable viral load: successful treatment with hydroxychloroquine and review of the literature

Faris Shweikeh?1,?Yaritza Torres?2,?Khadeja Khan?3,?Mohamad Mouchli?4,?Inderprit Singh?5

Immunol Res.?2025 Feb 21;73(1):55.?doi: 10.1007/s12026-025-09608-7.

57.

Prospective evaluation of the impact of repeated whole prison testing for hepatitis C

BMJ Open Gastroenterol.?2025 Feb 11;12(1):e001593.doi: 10.1136/bmjgast-2024-001593.

Naw April Phaw?1,?Aung Min Thant?2,?Craig Thompson?3,?Ryan Jelley?1,?Kate McQue?1,?Jodi Aldridge?3,?Caroline Allsop?1,?Jenna Kerry?1,?Francesca McCullough?1,?Carolyn Miller?1,?Manoj Valappil?4,?Tony Jefferson?5,?Colin Lawton?5,?Lee Christensen?5,?Stuart McPherson?6?7

58.

For your consideration: Benefits of listing as willing to consider heart offers from donors with hepatitis C

Thorac Cardiovasc Surg.?2025 Mar;169(3):932-940.?doi: 10.1016/j.jtcvs.2024.06.025.Epub 2024 Jun 28.

Jessica M Ruck?1,?Emily Rodriguez?1,?Alice L Zhou?1,?Christine M Durand?2,?Allan B Massie?3,?Dorry L Segev?4,?Antonio Polanco?1,?Errol L Bush?1,?Ahmet Kilic?5

59.

Effectiveness and safety of glecaprevir/pibrentasvir for 8 weeks in the treatment of patients with acute hepatitis C: A single-arm retrospective study

Hepatology.?2025 Mar 1;81(3):1006-1018.?doi: 10.1097/HEP.0000000000000923.Epub 2024 May 20.

Stanislas Pol?1?2,?Alexander J Thompson?3?4,?Michelle Collins?5,?Elisa Venier?6,?Laurent Cotte?7,?Montserrat Laguno Centeno?8,?Jorge Mera?9,?Thomas Reiberger?10,?Margaret Burroughs?11,?Dimitri G Semizarov?5,?Alexandru M Iacob?12,?Anne Welhaven?11,?Linda M Fredrick?11,?Joseph S Doyle?13?14

60.	Trends of the incidence rate of Hepatitis C in Changsha, China, 2005 to 2023 and Its Prediction to 2025.
	J Infect Dev Ctries.2025 Jan 31;19(1):140-145.doi:10.3855/jidc.19790
	Chen, Shuilian (S);Zeng, Ping (P);Yang, Kewei (K);Zhang, Xixing (X);Yang, Xuewen (X);Zhou, Yinzhu (Y);

61.	Dried blood spot as alternative specimen for molecular epidemiology studies among HCV/HIV coinfected patients.
	Braz J Infect Dis.2025 Feb 21;29(2):104512.doi:10.1016/j.bjid.2025.104512
	Flores, Geane (G);Lago, Barbara Vieira (BV);Caetano, Amanda R (AR);Silva, Jessica (J);Marques, Vanessa (V);Brandão-Mello, Carlos Eduardo (CE);Amendola-Pires, Marcia (M);Pilotto, Jose (J);Lewis-Ximenez, Lia (L);Villar, Livia Melo (LM);

62.	Advancing high-throughput anti-HCV drug screening: a novel dual-reporter HCV replicon model with real-time monitoring.
	Res Pharm Sci.2025 Feb 20;20(1):41-54.doi:10.4103/RPS.RPS_249_23
	Chitsombat, Kanokwan (K);Chimnaronk, Sarin (S);Sa-Ngiamsuntorn, Khanit (K);Chomnawang, Mullika Traidej (MT);Thirapanmethee, Krit (K);

63.	Does HCV treatment completion affect the neurocognitive outcomes in patients on opioid agonist maintenance treatment: A secondary analysis.
	Indian J Psychiatry.2025 Feb 19;67(2):260-266.doi:10.4103/indianjpsychiatry.indianjpsychiatry_900_24
	Ghosh, Abhishek (A);Verma, Abhishek (A);De, Arka (A);Premkumar, Madhumita (M);Duseja, Ajay (A);Nehra, Ritu (R);Basu, Debasish (D);

64.	Depression among people living with tuberculosis and tuberculosis/HIV coinfection in Ukraine: a cross-sectional study.
	Glob Health Action.2025 Feb 13;18(1):2448894.doi:10.1080/16549716.2024.2448894
	Salnikova, Anna (A);Makarenko, Olena (O);Sereda, Yuliia (Y);Kiriazova, Tetiana (T);Lunze, Karsten (K);DeHovitz, Jack (J);Ompad, Danielle C (DC);

65.	Impact of COVID-19 on key populations and people living with HIV: recommendations and sociopolitical responses from the EPIC community research program in Latin America.
	BMC Public Health.2025 Mar 12;25(1):971.doi:10.1186/s12889-025-22017-7
	Stuardo Ávila, Valeria (V);Apffel Font, Océane (O);León Cáceres, Ángela (Á);Radusky, Pablo (P);Aristegui, Ines (I);Mendoza, Harold (H);Veras, Maria (M);Pinheiro, Rodrigo (R);Mesa, Duvan Felipe (DF);Barriga, Miguel Ángel (MÁ);Gómez, Luis (L);Reyes-Díaz, Michael (M);Parra, Víctor (V);Lisboa Donoso, Cristian (C);Kretzer, Lisa (L);Castro Ávila, Juliana (J);Delabre M, Rosemary (R);Riegel, Lucas (L);Folch Toda, Cinta (C);Casabona, Jordi (J);Cáceres, Carlos F (CF);Lorente, Nicolas (N);Rojas-Castro, Daniela (D);

66.	MRSA-positive sternoclavicular septic arthritis mimicking mediastinal malignancy in a patient with multiple injection history: a rare case report.
	Ann Med Surg (Lond).2025 Feb 07;87(3):1733-1737.doi:10.1097/MS9.0000000000003042
	Shakeel, Muzammil (M);Saleem, Saad (S);Ali, Huzafa (H);Saqib, Huzaifa (H);Adhikari, Dipendra (D);Nazeef, Ayesha (A);Tariq, Aisha (A);Ud-Din, Zeeshan (Z);Kamran, Maheen (M);

67.	Insights into the spatial epidemiology of hepatitis C infection: systematic synthesis of area-level determinants and spatiotemporal analyses.
	BMC Public Health.2025 Feb 19;25(1):687.doi:10.1186/s12889-025-21668-w
	Gizamba, Jacob Mugoya (JM);Finch, Brian Karl (BK);Wang, Siqin (S);Klausner, Jeffrey D (JD);

68.	Acceptability of self-sampling and self-testing for infections: a rapid systematic review on public users' views.
	BMC Public Health.2025 Feb 20;25(1):695.doi:10.1186/s12889-025-21773-w
	Borek, Aleksandra J (AJ);Roleston, Caity (C);Lazzarino, Runa (R);Cooray, Mineli (M);Hayward, Gail (G);Roberts, Nia (N);Blandford, Edward (E);Fowler, Tom (T);Tonkin-Crine, Sarah (S);

69.	Rare bilateral corneoscleral perforation secondary to ocular tuberculosis: a case report and clinical insights.
	J Ophthalmic Inflamm Infect.2025 Mar 05;15(1):16.doi:10.1186/s12348-025-00472-y
	Dreyer, Justin (J);Kiryakoza, Lauren (L);Tijerina, Jonathan (J);Albini, Thomas (T);Amescua, Guillermo (G);

70.	Prevalence of HIV and Hepatitis C and access to opioid substitution treatment among people who inject drugs in three cities in Croatia: findings from the second wave of respondent-driven sampling surveys.
	Harm Reduct J.2025 Mar 04;22(1):26.doi:10.1186/s12954-025-01174-3
	Ševi?, Sandra (S);Koleti?, Goran (G);Blaži?, Tatjana Nemeth (TN);Kosanovi? Li?ina, Mirjana Lana (ML);Andrei?, Josipa-Lovorka (JL);Handanagi?, Senad (S);Pavi?, Magda Pletikosa (MP);Boži?evi?, Ivana (I);

71.	An evaluation of the performance of the PAP-PCR method in detecting UGT1A1 gene polymorphisms.
	Mol Biol Rep.2025 Mar 04;52(1):280.doi:10.1007/s11033-025-10391-9
	Kong, Xiangsha (X);Feng, Bo (B);Huang, Zixiang (Z);Rao, Huiying (H);Chen, Hongsong (H);Liu, Feng (F);Liu, Xiaofang (X);Shi, Yijun (Y);Wu, Nan (N);

72.	Cigarette smoking and attempts to quits among adults receiving federal housing assistance from 2005 to 2018, NHIS-HUD linked data.
	BMC Public Health.2025 Feb 24;25(1):766.doi:10.1186/s12889-025-21973-4
	Bachand, Jacqueline V (JV);Garrison, Veronica E (VE);Reyes, Brenda M (BM);Pollack, Craig Evan (CE);

73.	Changes in serum myostatin levels among patients with type C liver cirrhosis treated with direct-acting antivirals.
	Hepatol Res.2025 Jan 22;55(5):631-637.doi:10.1111/hepr.14162
	Suehiro, Tomoyuki (T);Kozuru, Hideko (H);Matusmoto, Kosuke (K);Kugiyama, Yuki (Y);Motoyoshi, Yasuhide (Y);Saeki, Akira (A);Nagaoka, Shinya (S);Yamasaki, Kazumi (K);Komori, Atsumasa (A);Yatsuhashi, Hiroshi (H);

74.	Adapted hepatitis C virus clone infects innate immunity-deficient mouse hepatocytes with minimal human HCV entry factors.
	JHEP Rep.2025 Jan 18;7(5):101328.doi:10.1016/j.jhepr.2025.101328
	Sheldon, Julie Ann (JA);Winkler, Melina (M);Yuan, Qinggong (Q);Frericks, Nicola (N);Phillip Brown, Richard John (RJ);Miskey, Csaba (C);Gödecke, Natascha (N);Behme, Sara (S);Rox, Katharina (K);Mysegades, Giorgia (G);Vondran, Florian (F);Wirth, Dagmar (D);Pietschmann, Thomas (T);

HEPATITIS

HBV
HCV
HDV

CLD HEALTH OUTCOMES

CIRRHOSIS

Cirrhosis
HE
HRS
Thrombocytopenia

MASH

Slide Library
Publications
Webcasts
Abstract Library Committee Members

CHOLESTATIC

PBC

HCC

Slide Library
Publications
Webcasts
Algorithm
Abstract Library Committee Members

ALCOHOL LIVER DISEASE

Recorded Educational Webinar

PEDIATRIC LIVER DISEASE

Webcasts
Slide Library
Abstract Library

About CLDF

Board of Trustees
Board of Advisors/Faculty
CLDF Committees
2025 GI Fellow Board of Advisors

Other Resources

Journal Abstracts

The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2025 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.

Subscribe